Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
doxylamine/pyridoxine (Diclectin, Diclegis)
print preview
bookmark
share with colleague
General Information
Company
Duchesnay Inc.
Description
Delayed-release tablet containing 10 mg doxylamine and 10 mg pyridoxine
Molecular Target
Mechanism of Action
Latest Stage of Development
Marketed
Indication
Emesis
Partner
Tzamal Medical Group Ltd.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information